IL17A and cancer: As shown above in Fig. 3d, this module is enriched in inflammatory signaling pathways (TNF-α, IL-17, and NFκΒ) and hallmarks of cancer (IL-2 and IL-6 signaling, interferon-gamma response and hypoxia), even though it is a module that is more highly expressed in the adjacent normal compared to the actual tumor.